Search Results 41 – 60 of 62
Tuberculosis/HIV Coinfection
Limitations to Treatment Safety and Efficacy
Adherence to the Continuum of Care
Adverse Effects of Antiretroviral Agents
Cost Considerations and Antiretroviral Therapy
Drug-Drug Interactions
Overview: Drug-Drug Interactions between Antiretrovirals and Other Drugs
Drug-Drug Interactions: Protease Inhibitors and Other Drugs
Drug-Drug Interactions: Non-Nucleoside Reverse Transcriptase Inhibitors and Other Drugs
Drug-Drug Interactions: Nucleoside Reverse Transcriptase Inhibitors and Other Drugs
Drug-Drug Interactions: Integrase Strand Transfer Inhibitors and Other Drugs
Drug-Drug Interactions: CCR5 Antagonist and Other Drugs
Drug-Drug Interactions: HIV-1 gp120 Inhibitors and Other Drugs
Drug-Drug Interactions: Capsid Inhibitors and Other Drugs
Drug-Drug Interactions: Non-Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors
Drug-Drug Interactions: Integrase Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors or Protease Inhibitors
Appendix A: Drug Characteristics Tables
Appendix B. Antiretroviral Dosing Recommendations in Adults With Renal or Hepatic Insufficiency
Appendix C: Key to Acronyms
Appendix C: Drug Name Abbreviations